Leadership Team

Expertise, insight and commitment to deliver on strategy

Opus Genetics is led by a seasoned leadership team with deep expertise across ophthalmology, gene therapy, and drug development and commercialization. The team brings decades of experience advancing therapies from early research through pivotal trials, regulatory approval, and commercialization, with a shared focus on scientific rigor, patient impact, and disciplined execution.

George Magrath, MD, MBA, MS
Chief Executive Officer
Jean Bennett, MD, PhD
Scientific Advisor
Ben Yerxa, PhD
President
Robert Gagnon, CPA, MBA
Chief Financial Officer
Joe Schachle
Chief Operating Officer
Ash Jayagopal, PhD, MBA
Chief Scientific and Development Officer
Sally Tucker, PhD
Senior Vice President Clinical Development
Sarah Tuller, JD
Chief Regulatory Officer